The most notable finding is ESRT's YTD outperformance of roughly 8 percentage points versus the S&P, which signals that its portfolio mix or recent lease activity may be delivering incremental cash flow stability despite macro headwinds.
A key risk is the cumulative 33% loss over the past year, which far exceeds the S&P's 56.7% decline; this steep drop reflects heightened sensitivity to rising financing costs and potential lease expirations in high‑cost NYC locations, potentially eroding cash flow if interest rates remain elevated.
While institutional ownership is high, the 1.92% increase may be modest relative to the overall float; a small reversal in sentiment could trigger a disproportionate sell‑off given the stock's 42.6% max drawdown history, especially if lease‑up targets miss expectations.
The key growth insight is the divergence between a 2.8% three‑year CAGR and the current 0.67% YoY rise, highlighting that recent market headwinds—particularly elevated office vacancy in New York—are suppressing momentum just as the trust aims to expand its portfolio.
The primary margin risk is the razor‑thin gross margin of 1.8%; a 0.5% increase in operating expenses (e.g., higher property taxes or maintenance costs) would cut net income by roughly $3.8 million, pressuring EPS and dividend sustainability.
The margin expansion to 6.2% is the most positive signal, as it demonstrates that ESRT can boost earnings even amid a challenging office market, supporting the thesis that rent‑growth and expense discipline can sustain cash flow despite lower leverage.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 4.5 | 6.2 | 0.17 | 4.22 | 14.2 | 3.1 | 1.1 |
| 2024 | 5.0 | 6.8 | 0.17 | 4.38 | 16.8 | 4.2 | 1.1 |
| 2023 | 5.4 | 7.2 | 0.18 | 4.28 | 14.9 | 4.0 | 1.3 |
| 2022 | 4.3 | 5.7 | 0.17 | 4.36 | 13.9 | 3.5 | 1.0 |
| 2021 | -0.7 | -1.1 | 0.14 | 4.29 | 7.9 | 2.1 | -0.2 |
| 2020 | -1.2 | -2.1 | 0.15 | 3.93 | 5.0 | 1.6 | -0.3 |
| 2019 | 4.2 | 7.0 | 0.19 | 3.20 | 11.2 | 4.0 | 1.3 |
| 2018 | 5.4 | 9.1 | 0.17 | 3.39 | 5.1 | 4.7 | 1.6 |
| 2017 | 5.4 | 8.9 | 0.18 | 3.37 | 5.6 | 5.2 | 1.6 |
| 2016 | 4.5 | 7.7 | 0.17 | 3.37 | 5.4 | 5.0 | 1.3 |
| 2015 | 6.6 | 5.3 | 0.20 | 6.29 | 5.9 | 5.2 | 1.1 |
The relatively low asset turnover (0.17x) translates to slower capital deployment efficiency; if vacancy rates rise further, ROIC could be pressured as fixed asset bases generate diminishing incremental returns.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 2123 | 0 | 132 | 13 | 31 | 101 |
| 2024 | 2157 | 0 | 215 | 13 | 56 | 159 |
| 2023 | 2082 | 0 | 146 | 14 | 48 | 98 |
| 2022 | 2149 | 0 | 136 | 15 | 37 | 99 |
| 2021 | 2571 | 0 | 146 | 17 | 54 | 92 |
| 2020 | 2487 | 0 | 146 | 17 | 41 | 106 |
| 2019 | 1962 | 0 | 123 | 15 | 38 | 85 |
| 2018 | 2094 | 0 | 115 | 1062 | 40 | 73 |
| 2017 | 2014 | 0 | 106 | 1026 | 39 | 67 |
| 2016 | 2095 | 0 | 94 | 1020 | 46 | 47 |
| 2015 | 1832 | 0 | 78 | 1001 | 103 | -24 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $4469M | $2647M | $1060M | $2439M | $2273M | $167M | $189M | $60M |
| 2024 | $4510M | $2728M | $1031M | $2484M | $2098M | $385M | $879M | $766M |
| 2023 | $4219M | $2488M | $986M | $2269M | $1922M | $347M | $702M | $559M |
| 2022 | $4164M | $2481M | $954M | $2275M | $2010M | $264M | $615M | $552M |
| 2021 | $4282M | $2598M | $998M | $2339M | $1916M | $424M | $718M | $568M |
| 2020 | $4151M | $2419M | $1055M | $2166M | $1639M | $527M | $889M | $570M |
| 2019 | $3932M | $1984M | $1229M | $1698M | $1464M | $234M | $583M | $72M |
| 2018 | $4196M | $2205M | $1238M | $1919M | $1714M | $205M | $965M | $175M |
| 2017 | $3931M | $1954M | $1168M | $1689M | $1224M | $464M | $798M | $152M |
| 2016 | $3891M | $1908M | $1154M | $1612M | $1058M | $554M | $844M | $166M |
| 2015 | $3301M | $1928M | $525M | $1632M | $1586M | $47M | $304M | $403M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $249M | $-550M | $38M | $-198M | $51M | $-8M | $-24M |
| 2024 | $261M | $-397M | $159M | $261M | $-23M | ||
| 2023 | $232M | $-77M | $-63M | $232M | $-13M | $-23M | |
| 2022 | $211M | $-231M | $-140M | $-126M | $85M | $-90M | $-23M |
| 2021 | $212M | $-213M | $-93M | $-95M | $117M | $-47M | $-18M |
| 2020 | $182M | $-143M | $257M | $-143M | $39M | $-144M | $-37M |
| 2019 | $233M | $150M | $-382M | $-250M | $-18M | $-75M | |
| 2018 | $279M | $-643M | $105M | $-243M | $36M | $-71M | |
| 2017 | $191M | $-225M | $-57M | $-223M | $-32M | $-67M | |
| 2016 | $219M | $-182M | $471M | $-182M | $36M | $-56M | |
| 2015 | $203M | $-142M | $-60M | $-142M | $61M | $-39M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-08 · finexus.net